NCT03540017 2022-11-02
HIPEC After Initial CRS in Patients Who Have Received NACT
Northwell Health
Phase 1 Unknown
Northwell Health
Massachusetts General Hospital
Lee's Pharmaceutical Limited
Critical Outcome Technologies Inc.
British Columbia Cancer Agency
Oncolix, Inc.